Literature DB >> 23767967

Early growth and non-alcoholic fatty liver disease in adulthood-the NAFLD liver fat score and equation applied on the Helsinki Birth Cohort Study.

Samuel Sandboge1, Mia-Maria Perälä, Minna K Salonen, Paul A Blomstedt, Clive Osmond, Eero Kajantie, David J P Barker, Johan G Eriksson.   

Abstract

INTRODUCTION: Prenatal and childhood growth influence the risk of developing the metabolic syndrome and type 2 diabetes. Both conditions are associated with non-alcoholic fatty liver disease (NAFLD). Our aim was to explore the associations between early growth and adult NAFLD.
METHODS: We studied 1587 individuals from the Helsinki Birth Cohort Study (HBCS) born 1934-44 for whom birth, childhood, and adult clinical data were available. NAFLD was defined using the NAFLD liver fat score and equation. The score was converted into a dichotomous variable, with outcomes defined as either a positive or negative score. The equation predicts liver fat percentage.
RESULTS: A positive score was found in 43% of men and 22.5% of women. Several measurements of birth and childhood body size were negatively associated with both NAFLD outcomes after adjustment for adult BMI. Those from the smallest BMI tertile at age 2 who were obese in adulthood had an OR of 18.5 for a positive score compared to those from the same group who were normal weight in adulthood.
CONCLUSIONS: A larger childhood body size was negatively associated with NAFLD outcomes. Individuals who are small during early childhood and obese as adults seem to be at the highest risk of developing NAFLD.

Entities:  

Mesh:

Year:  2013        PMID: 23767967     DOI: 10.3109/07853890.2013.801275

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  15 in total

1.  Prevalence of NAFLD in Guatemala following exposure to a protein-energy nutrition intervention in early life.

Authors:  Ahlia Sekkarie; Siran He; Jean A Welsh; Usha Ramakrishnan; Aryeh D Stein; Miriam B Vos
Journal:  Ann Hepatol       Date:  2020-05-16       Impact factor: 2.400

2.  Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease.

Authors:  Elisabetta Bugianesi; Carla Bizzarri; Chiara Rosso; Antonella Mosca; Nadia Panera; Silvio Veraldi; Andrea Dotta; Germana Giannone; Massimiliano Raponi; Marco Cappa; Anna Alisi; Valerio Nobili
Journal:  Am J Gastroenterol       Date:  2017-05-30       Impact factor: 10.864

3.  Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.

Authors:  Yinkun Yan; Dongqing Hou; Xiaoyuan Zhao; Junting Liu; Hong Cheng; Youfa Wang; Jie Mi
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

4.  Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.

Authors:  E W Harville; W Chen; L Bazzano; M Oikonen; N Hutri-Kähönen; O Raitakari
Journal:  J Dev Orig Health Dis       Date:  2016-12-06       Impact factor: 2.401

5.  Subcutaneous fat mass in infancy and abdominal, pericardial and liver fat assessed by Magnetic Resonance Imaging at the age of 10 years.

Authors:  Bernadeta Patro Golab; Ellis Voerman; Aad van der Lugt; Susana Santos; Vincent W V Jaddoe
Journal:  Int J Obes (Lond)       Date:  2018-12-19       Impact factor: 5.095

Review 6.  Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life.

Authors:  Minglan Li; Clare M Reynolds; Stephanie A Segovia; Clint Gray; Mark H Vickers
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

7.  Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register.

Authors:  Esther Zimmermann; Michael Gamborg; Claus Holst; Jennifer L Baker; Thorkild I A Sørensen; Tina L Berentzen
Journal:  BMJ Open       Date:  2015-05-03       Impact factor: 2.692

8.  Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study.

Authors:  Emma L Anderson; Laura D Howe; Abigail Fraser; Mark P Callaway; Naveed Sattar; Chris Day; Kate Tilling; Debbie A Lawlor
Journal:  J Hepatol       Date:  2014-04-24       Impact factor: 25.083

Review 9.  Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns.

Authors:  Preetam Nath; Shivaram P Singh
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

10.  Hepatic Tumor Formation in Adult Mice Developmentally Exposed to Organotin.

Authors:  Tiffany A Katz; Sandra L Grimm; Akhilesh Kaushal; Jianrong Dong; Lindsey S Treviño; Rahul K Jangid; Adriana V Gaitán; Jean-Philippe Bertocchio; Youchen Guan; Matthew J Robertson; Robert M Cabrera; Milton J Finegold; Charles E Foulds; Cristian Coarfa; Cheryl Lyn Walker
Journal:  Environ Health Perspect       Date:  2020-01-15       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.